CH
CHRS
Coherus Oncology, Inc. $1.43 1M +25.4% 3M +2.1% YTD +4.4% as of 2026-09-14↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset
▲ buy ▼ sell · size ≈ trade size · ─ moving averages · click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.4%
Next 1 week
-1.6%
Next 1 month
-1.2%
Seasonality
Weak window historically
Next 30 days (to Oct 15): -8.9% median,
27% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Overbought — RSI(2) at 88
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is +0.43%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.87 -0.9% · Seasonal tilt (11y) -0.4%
$1M/day volume
81% volatility
+8% 1-year
52-week range · 22% of the way up · -45% from the high
$1.09$2.62
Congressional trades in CHRS Full tracker →
1 member · 0 buys / 1 sells · $15K–$50K disclosed · latest filing Feb 9, 2023.
| SELL | $15K–$50K |
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.